Congress·In Committee·H.R. 8358

Breast Cancer Research Stamp Reauthorization Act of 2026

Breast Cancer Research: Extending Special Stamp Sales

3 months ago·View on Congress.gov·Read full text

This bill is currently in the early stages of the legislative process and is being reviewed by three different House committees. It is actively moving forward as it waits for these groups to finish their initial evaluations. There are no upcoming votes scheduled at this time.

Legislative Progress

House

Senate

President

Law

Very likely to pass

This is a popular, bipartisan program with a long history of being renewed. It raises money for a cause most people support without costing taxpayers anything.

Key Points

This bill allows the U.S. Postal Service to keep selling a special stamp that raises money for breast cancer research. The current permission for this stamp is set to end in 2027, but this change would keep it going until 2037.
People who buy these stamps pay a little more than the price of a regular first-class stamp. The extra money goes directly to the National Institutes of Health and the Department of Defense to fund medical research.
This program is a way for regular citizens to donate to cancer research while doing their everyday mailing. It does not use taxpayer money because the donations come from the people who choose to buy the stamps.
A bipartisan group of lawmakers from both parties supports this extension. They want to make sure there is no gap in funding for research that helps find better treatments and cures for breast cancer.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.

Milestones

2 milestones2 actions

Apr 16, 2026House

Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.

Apr 16, 2026

Introduced in House

The bill was officially filed and given a number. It now enters the legislative queue.

Votes

No votes have been recorded for this legislation yet.

News

No related news coverage found for this legislation yet.

Source Information

Document Type

Congressional Bill

Official Title

Breast Cancer Research Stamp Reauthorization Act of 2026

Bill NumberHR 8358

Congress119th Congress

ChamberHouse of Representatives

Latest ActionReferred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.